Pharm Success Qs Ch 7 Genitourinary May 2019 .docx - KEY All un-highlighted questions are required for Patho-Pharm 1 Red Text = Should Understand Green

Pharm Success Qs Ch 7 Genitourinary May 2019 .docx - KEY...

This preview shows page 1 - 3 out of 11 pages.

KEY: All un-highlighted questions are required for Patho-Pharm 1 Red Text = Should Understand Green Text = Absolutely Should Know Yellow Highlight = Patho-Pharm 2 Material (Skip in Patho-Pharm 1) Blue Highlight = Skip (In both Patho-Pharm 1 & 2) Chapter 7 GENITOURINARY SYSTEM A Client with Chronic Kidney Disease 1.The client diagnosed with chronic kidney disease is prescribed erythropoietin(Epogen), a biologic response modifier. Which statement best describes the scientific rationale for administering this medication? 1.This medication stimulates red blood cell production. 2.This medication stimulates white blood cell production. 3.This medication is used to treat thrombocytopenia. 4.This medication increases the production of urine. 2.Which intervention should the nurse implement when administering the biological response modifier erythropoietin (Epogen) subcutaneously? Select all that apply. 1.Do not shake the vial prior to preparing the injection. 2.Apply a warm washcloth after administering the medication. 3.Discard any unused portion of the vial after pulling up the correct dose. 4.Keep the medication vials in the refrigerator until preparing to administer. 5.Administer the medication intramuscularly in the deltoid muscle. 3.Which statement best describes the scientific rationale for administering aluminum hydroxide (Amphojel), an antacid, to a client in chronic kidney disease (CKD)? 1.This medication neutralizes gastric acid production. 2.It binds to phosphorus to help decrease hyperphosphatemia. 3.The medication is administered to decrease the calcium level. 4.It will help decrease episodes of constipation in the client with CKD. 4.Which statement best describes the scientific rationale for administering calcitriol (Rocaltrol), a vitamin D analog, to a client in end-stage kidney disease? 1.This medication increases the availability of vitamin D in the intestines. 2.This medication stimulates excretion of calcium from the parathyroid gland. 3.The medication helps the body excrete calcium through the feces. 4.This medication increases serum calcium levels by promoting calcium absorption. 5.The client in end-stage renal disease (ESRD) is taking calcitriol, a vitamin D analog. Which assessment data warrants intervention by the nurse? 1.The client complains of nausea. 2.The client has had two episodes of diarrhea. 3.The client has an increase in the serum creatinine level. 4.The client has blood in the urine. 6.The client in chronic kidney disease is taking aluminum hydroxide (Amphojel), a liquid antacid. Which information should the nurse discuss with the client? 1.Drink at least 500 mL of water after taking the medication. 2.Do not drink any water for 1 hour after taking the medication.
Image of page 1
3.Drink 2–4 ounces of water after taking the medication. 4.Eat 30 minutes prior to taking the aluminum hydroxide.
Image of page 2
Image of page 3

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture